au.\*:("HOSAKA, Yoshitaka")
Results 1 to 6 of 6
Selection :
Inhibition of invasion and experimental metastasis of murine melanoma cells by human soluble thrombomodulinHOSAKA, Yoshitaka; HIGUCHI, Toshiyuki; TSUMAGARI, Michiko et al.Cancer letters. 2000, Vol 161, Num 2, pp 231-240, issn 0304-3835Article
Toll-like receptor 4 signal transduction inhibitor, M62812, suppresses endothelial cell and leukocyte activation and prevents lethal septic shock in miceNAKAMURA, Masaki; SHIMIZU, Yusuke; SATO, Yasuko et al.European journal of pharmacology. 2007, Vol 569, Num 3, pp 237-243, issn 0014-2999, 7 p.Article
Effect of trapidil on effector functions of monocytes related to atherosclerotic plaqueKATO, Yutaka; TSUDA, Toshihiko; HOSAKA, Yoshitaka et al.European journal of pharmacology. 2001, Vol 428, Num 3, pp 371-379, issn 0014-2999Article
Pharmacological characterization of the active synthetic factor Xa inhibitors M55551 and M55165HOSAKA, Yoshitaka; MATSUMOTO, Miwa; ISHII, Hidemi et al.European journal of pharmacology. 2006, Vol 529, Num 1-3, pp 164-171, issn 0014-2999, 8 p.Article
Inhibitory effect of M50054, a novel inhibitor of apoptosis, on anti-Fas-antibody-induced hepatitis and chemotherapy-induced alopeciaTSUDA, Toshihiko; OHMORI, Youko; MOCHIZUKI, Hidenori et al.European journal of pharmacology. 2001, Vol 433, Num 1, pp 37-45, issn 0014-2999Article
Synthesis and evaluation of 1-arylsulfonyl-3-piperazinone derivatives as factor Xa inhibitorNISHIDA, Hidemitsu; MIYAZAKI, Yutaka; KITAMURA, Yoshihiro et al.Chemical and pharmaceutical bulletin. 2001, Vol 49, Num 10, pp 1237-1244, issn 0009-2363Article